“Choosing Providence Ventures as a strategic investment partner early on in Lyra’s evolution has proven to be very valuable. The PV team has engaged closely with us from the outset to build collaborative relationships with Providence’s operational and clinical leaders that have helped us more effectively develop our solution to meet the needs of our customers.”

– David Ebersman, CEO of Lyra Health